Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Wen-lian Wu"'
Autor:
Martin Dolmaski, Brandon M. Taoka, Jared N. Cumming, Maria S. Michener, Lynn A. Hyde, Jinsong Hao, Brad E. Smith, Hongwu Wang, Wen-Lian Wu, Matthew E. Kennedy, Dorthy Levorse, Peter Orth, Eric M. Parker
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 56:128463
This paper describes the structure-activity-relationships of novel fluoroalkyl substituents at the C2 position of iminothiazine dioxide beta secretase inhibitors. Key discoveries include reduced amidine basicity and its effect on Pgp, cell potency, a
Publikováno v:
Cancer Research. 81:1145-1145
Background: Protein arginine methyltransferase 5 (PRMT5) is an attractive therapeutic target because of its involvement in key oncogenic mechanisms including epigenetics, DNA response and RNA processing. Early development of PRMT5 inhibitors has focu
Publikováno v:
Cancer Research. 81:1286-1286
AGX87 - An IND-stage potent and selective next-generation NTRK/ROS1 inhibitor of WT and clinical resistant mutants with superiority over tyrosine kinase inhibitors currently approved or in development Background: Fusions of the neurotrophic receptor
Autor:
Bo Su, Tai-Gang Zhou, Xian-Wei Li, Xiao-Ru Shao, Pei-Lin Xu, Wen-Lian Wu, John F. Hartwig, Zhang-Jie Shi
Publikováno v:
Angewandte Chemie. 129:1112-1116
Autor:
Theresa M. Kelly, John W. Clader, Dmitri A. Pissarnitski, Johannes H. Voigt, Duane A. Burnett, David Cole, Giovanna Scapin, Wen-Lian Wu, Zuliang Yao, Aileen Soriano, Zhiqiang Zhao, Martin S. Domalski, Mary Ann Powles
Publikováno v:
Bioorganic & Medicinal Chemistry. 24:5534-5545
Molecular modeling of unbound tricyclic guanine scaffolds indicated that they can serve as effective bioisosteric replacements of xanthines. This notion was further confirmed by a combination of X-ray crystallography and SAR studies, indicating that
Autor:
Hong Liu, Shawn P. Walsh, Yan Qi, Jiaqiang Cai, Jack D. Scott, Xin-Jie Chu, Cuizhi Mu, Brandon M. Taoka, Yaxian Cai, Jinsong Hao, Quang Truong, Zhong Lai, Xing Dai, Wen-Lian Wu, Jeffrey T. Kuethe, Eric J. Gilbert, Andrew Brunskill, Jared N. Cumming
Publikováno v:
Tetrahedron. 72:6011-6020
A novel domino reaction for the preparation of non-racemic β-proline derivatives is reported. The addition of a methyl 2-(oxetan-3-yl)acetate titanium enolate to chiral tert-butanesulfinyl ketimines followed by an intramolecular oxetane ring-opening
Publikováno v:
Cancer Research. 80:1942-1942
HCC is the second leading cause of cancer-related death and the fifth-most-common cancer worldwide. Unlike almost all other tumor types, the vast majority (90%) of HCCs develop due to underlying chronic inflammation, the induction of fibrosis and/or
Publikováno v:
ChemCatChem. 7:2986-2990
The Rh-catalyzed reaction of N-phthalimidyl benzamides (I) with diaryl alkynes (II) in the presence of Cu(O-Ac)2 and O2 leads to N-phthalimidyl 3,4-diarylisoquinolinones (III), whilst the reaction in the presence of cesium acetate under nitrogen give
Publikováno v:
Molecular Cancer Therapeutics. 18:C082-C082
One of the central hypotheses of modern targeted cancer treatment paradigm is that aberrant activation and/or over-expression of oncogenic kinases drive intrinsic cancer cell proliferation and survival and is the causative event in cancer initiation
Autor:
Ruo Xu, Monica Vicarel, Lili Zhang, Duane A. Burnett, Giuseppe Terracina, Lynn A. Hyde, Wen-Lian Wu, Qi Zhang, Thomas Bara, William J. Greenlee, Robert A. Del Vecchio, Amin A. Nomeir, Mcbriar Mark D, Mary Cohen-Williams, Josien Hubert B, Murali Rajagopalan, Julie Lee, Theodros Asberom, Martin S. Domalski, John W. Clader, Chad Bennett, Lixin Song, Eric M. Parker
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 23:844-849
An investigation is detailed of the structure activity relationships (SAR) of two sulfone side chains of compound (−)- 1a (SCH 900229), a potent, PS1-selective γ-secretase inhibitor and clinical candidate for the treatment of Alzheimer’s disease